TWD
LEGN icon

True Wealth Design’s Legend Biotech LEGN Stock Holding History

True Wealth Design’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.15K Buy
109
+90
+474% +$2.43K ﹤0.01% 1519
2026
Q1 		$344 Buy
+19
New +$362 ﹤0.01% 2178

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

True Wealth Design's LEGN Position: Q2 2026 in Review

True Wealth Design increased its Legend Biotech (LEGN) stake by 474% in Q2 2026, buying an estimated $2.43K and bringing the position to 109 shares worth $3.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1519.

True Wealth Design first reported a position in LEGN in Q1 2026 and has held it in 2 quarters since. 218 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • True Wealth Design held 109 shares of Legend Biotech worth $3.15K as of Q2 2026.
  • True Wealth Design bought 90 Legend Biotech shares in Q2 2026, an estimated $2.43K.
  • Legend Biotech made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1519 holding.
  • True Wealth Design first reported a position in Legend Biotech in Q1 2026 and has held it in 2 quarters since.
  • 218 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.